This inventor holds 1 USPTO granted patent. Top assignees: Anges Mg, Inc., Osaka University. Active years: 2016.
Company Filing History:
1 out of 29 
1 out of 1,039 
Years Active: 2016
Title: Natsuki Yoshida: Innovator in DNA Vaccine Technology
Introduction
Natsuki Yoshida is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of DNA vaccines. Her innovative work aims to address lifestyle-related diseases through advanced therapeutic methods.
Latest Patents
Natsuki Yoshida holds a patent for a DNA vaccine that provides a therapeutic or improving agent for lifestyle-related diseases. The invention includes an expression vector encoding a chimeric Hepatitis B virus core antigen polypeptide. This polypeptide is inserted with an amino acid sequence containing a specific epitope of the lifestyle-related disease-related factor. Notably, the amino acid sequence is inserted between the amino acid residues 80 and 81 of the hepatitis B virus core antigen polypeptide. This patent showcases her expertise in genetic engineering and vaccine development.
Career Highlights
Throughout her career, Natsuki has worked with esteemed institutions such as Osaka University and Anges Mg, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Natsuki Yoshida has collaborated with notable colleagues, including Ryuichi Morishita and Hironori Nakagami. These partnerships have further enhanced her research and development efforts in the biotechnology sector.
Conclusion
Natsuki Yoshida is a trailblazer in the field of DNA vaccine technology, with a focus on combating lifestyle-related diseases. Her innovative patent and collaborations with esteemed institutions highlight her significant contributions to biotechnology.